PPIDT00054
Drug Information
| Name | Eptifibatide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB00063 |
| Type | biotech |
| Indication | For treatment of myocardial infarction and acute coronary syndrome. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravenous |
|
| Injection | Intravenous |
0.75 mg/1mL
|
| Injection | Intravenous |
2 mg/1mL
|
| Injection | Intravenous |
20 mg/10mL
|
| Injection | Intravenous |
200 mg/100mL
|
| Injection | Intravenous |
75 mg/100mL
|
| Injection, solution | Intravenous |
0.75 mg/1mL
|
| Injection, solution | Intravenous |
2 mg/1mL
|
| Injection, solution | Intravenous |
20 mg/10mL
|
| Injection, solution | Intravenous |
200 mg/100mL
|
| Injection, solution | Intravenous |
75 mg/100mL
|
| Injection, solution | Intravenous |
0.75 MG/ML
|
| Injection, solution | Intravenous |
2 MG/ML
|
| Injection, solution | — |
|
| Injection | Intravenous |
|
| Injection, solution | Intravenous; Parenteral |
0.75 MG/ML
|
| Injection, solution | Intravenous; Parenteral |
2 MG/ML
|
| Solution | Intravenous |
0.75 mg / mL
|
| Solution | Intravenous |
2 mg / mL
|
| Solution | Intravenous |
2 mg/1ml
|
| Solution | Intravenous |
0.75 mg/1ml
|
| Solution | Intravenous |
0.75 mg
|
| Solution | Intravenous |
200000 mg
|
| Injection | Intravenous |
2 mg/ml
|
| Injection | Intravenous |
0.75 mg/ml
|